Clinical Trials · NCT05724134

Pancreatic Clamp in NAFLD

CompletedPhase 1Octreotide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Columbia University
Enrollment
18
Start date
Aug 2023
Locations
1 site, United States
Primary endpoint
Plasma glucose (absolute values) (units: mg/dL)
View Octreotide compound reference